文献速递糖尿病

高敏心肌肌钙蛋白T和N末端B型利钠肽原与1型糖尿病心血管结局的关系

High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2020-07-02

在581例1型糖尿病患者中分析储存标本的高敏心肌肌钙蛋白T(hs-cTnT)和N末端B型利钠肽原(NT-proBNP),随访21年。两者均独立预测心血管疾病(CVD)和主要不良心血管事件(MACE),但加入传统风险因素模型后未显著改善CVD或MACE的预测(曲线下面积未增加)。观察到hs-cTnT的预测作用仅限于男性的边缘显著性别交互(P=0.06)。

要点

  • hs-cTnT中位数男性高于女性(P<0.0001),NT-proBNP中位数无性别差异。
  • log hs-cTnT(HR 1.38,P=0.0006)和log NT-proBNP(HR 1.24,P=0.0001)独立预测CVD。
  • 两者加入传统风险因素模型后未显著改善CVD或MACE预测(曲线下面积未增加)。

核心结论

  • 在1型糖尿病中观察到hs-cTnT和NT-proBNP的浓度及预测能力存在性别差异,两者加入传统风险因素模型后未增加CVD或MACE的曲线下面积。

研究设计与样本

  • 研究分析了581例1型糖尿病患者首次可用的储存标本,平均年龄29岁、糖尿病病程21岁,使用Roche Cobas E601检测hs-cTnT和NT-proBNP,随访21年。

主要发现

  • hs-cTnT中位数5.0 ng/L(四分位距<3.0,10.0),男性高于女性(P<0.0001);NT-proBNP中位数22.0 ng/L(7.0,61.0),无性别差异。
  • Cox模型中log hs-cTnT(HR 1.38,P=0.0006)和log NT-proBNP(HR 1.24,P=0.0001)独立预测CVD,但单独或联合加入模型均未显著改善CVD预测。
  • 观察到边缘显著的性别交互(P=0.06),提示hs-cTnT的预测作用仅限于男性。
  • hs-cTnT和NT-proBNP也预测MACE,但两者同时纳入模型时仅NT-proBNP保持显著(HR 1.27,P=0.0009);加入多变量模型未增强MACE预测。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-sensitivity cardiac troponin-T (hs-cTnT) and N-terminal prohormone of B-type natriuretic peptide (NT-proBNP), biomarkers of cardiovascular disease (CVD) and heart failure, respectively, have not been widely studied in type 1 diabetes (T1D). We evaluated whether their assessment in T1D enhances the prediction of CVD and major adverse cardiovascular events (MACE). RESEARCH DESIGN AND METHODS: hs-cTnT and NT-proBNP were analyzed on the Roche Cobas E601 using the first available stored specimen (n = 581; mean age 29 years and diabetes duration 21 years). CVD was defined as CVD death, myocardial infarction, coronary revascularization, angina, ischemia, or stroke, and MACE as CVD death, myocardial infarction, or stroke. RESULTS: Median hs-cTnT (5.0 ng/L; interquartile range <3.0, 10.0) was higher among men (P < 0.0001), whereas median NT-proBNP (22.0 ng/L; 7.0, 61.0) did not differ by sex. In Cox models, log hs-cTnT (hazard ratio [HR] 1.38, P = 0.0006) and log NT-proBNP (HR 1.24, P = 0.0001) independently predicted CVD during 21 years of follow-up. However, their addition to models, singly or together, did not significantly improve CVD prediction. Furthermore, a marginally significant sex interaction was observed (P = 0.06), indicating that the hs-cTnT prediction was limited to men. hs-cTnT and NT-proBNP also predicted MACE, although only NT-proBNP remained significant (HR 1.27, P = 0.0009) when the biomarkers were included in a model simultaneously. Nonetheless, their addition to multivariable models did not enhance MACE prediction. CONCLUSIONS: Sex differences were observed in the concentration and predictive ability of hs-cTnT and NT-proBNP in T1D. Overall, their addition to traditional risk factor models increased the area under the curve for neither CVD nor MACE.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Costacou T, Saenger AK, Orchard TJ, et al. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes. Diabetes Care. 2020. PMID: 32616616. doi:10.2337/dc20-0359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。